Predictive Oncology Completes AI-driven Study Of Ovarian Cancer With UPMC Magee-Womens Hospital
Portfolio Pulse from Benzinga Newsdesk
Predictive Oncology Inc. (NASDAQ:POAI) has completed a multi-year study with UPMC Magee-Womens Hospital, using AI to build multi-omic machine learning models for ovarian cancer patient survival. The study used one of the largest sets of multi-omic data from 235 ovarian cancer patients. The models have the potential to become invaluable clinical support tools and could support the tailoring of therapies to individual patients.
November 08, 2023 | 1:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Predictive Oncology's completion of an AI-driven study with UPMC Magee-Womens Hospital could potentially enhance its reputation in the field of AI-driven drug discovery and biologics. The successful use of AI in creating predictive models for ovarian cancer patient survival could lead to increased interest in the company's services.
The successful completion of the study demonstrates Predictive Oncology's capabilities in using AI for drug discovery and biologics. This could potentially attract more partnerships and increase the company's market value. The potential of the models to become clinical support tools could also lead to increased demand for the company's services.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100